Peter Kabos

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Estrogen Receptor

Endoplasmic Reticulum

Transcription Factor

Top Venues

Molecular carcinogenesis

Clinical cancer research : an official journal of the American Association for Cancer Research

Science advances

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Komal L Jhaveri, Meritxell Bellet-Ezquerra, Nicholas C Turner, Sherene Loi, Aditya Bardia, Valentina Boni, Joo Hyuk Sohn, Tomas G Neilan, Rafael Villanueva-Vázquez, Peter Kabos, Laura García Estévez, Elena Lopez-Miranda, José Alejandro Pérez-Fidalgo, Jose Manuel Perez-Garcia, Jiajie Yu, Jill Fredrickson, Heather M Moore, Ching-Wei Chang, John W Bond, Jennifer Eng-Wong, Mary R Gates, Elgene Lim
Phase Ia/b Study of Giredestrant ±Palbociclib and ±Luteinizing Hormone-releasing Hormone Agonists in Estrogen Receptor-positive, HER2-negative, Locally Advanced/Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elena Shagisultanova, William J Gradishar, Ursa Brown-Glabberman, Pavani Chalasani, Andrew J Brenner, Alison T Stopeck, Hannah Parris, Dexiang Gao, Tessa Mcspadden, Jose Mayordomo, Jennifer R Diamond, Peter Kabos, Virginia F Borges
Safety and efficacy of tucatinib, letrozole and palbociclib in patients with previously treated HR+/HER2+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Satyanarayan Rao, Amy L Han, Alexis Zukowski, Etana Kopin, Carol A Sartorius, Peter Kabos, Srinivas Ramachandran
Transcription factor-nucleosome dynamics from plasma cfDNA identifies ER-driven states in breast cancer. Science advances 8 (34) (2022)
Aditya Bardia, Virginia G Kaklamani, Sharon Wilks, Amy Weise, Donald Richards, Wael Harb, Cynthia Osborne, Robert Wesolowski, Meghan Karuturi, Paul Conkling, Rebecca G Bagley, Yamei Wang, Maureen G Conlan, Peter Kabos
Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Heather M Brechbuhl, Mengyu Xie, Etana G Kopin, Amy L Han, Kiran Vinod-Paul, Jaime Hagen, Susan Edgerton, Philip Owens, Sharon Sams, Anthony Elias, Carol A Sartorius, Aik Choon Tan, Peter Kabos
Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor-positive breast cancer. Molecular carcinogenesis (2021)
Heather M Brechbuhl, Kiran Vinod-Paul, Austin E Gillen, Etana G Kopin, Kari Gibney, Anthony D Elias, Masanori Hayashi, Carol A Sartorius, Peter Kabos
Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells. Molecular carcinogenesis 59 (10) (2020)